Cardiovascular Research · 1988 · 14 citations · 0 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyHemodynamic ManagementPharmacodynamicsCardiac PharmacotherapyCardiovascular MedicineCardiovascular PharmacologyCoronary Artery DiseaseHemodynamicsIschemic Heart DiseaseBlood FlowCardiovascular Drug PharmacologyCollateral ChangesCollateral Circulation AugmentationCoronary Artery Disease PharmacotherapyPharmacodynamics Of Cardiovascular Drugs
The effects of glyceryl trinitrate on collateral blood flow and regional myocardial function during a 2 min coronary occlusion were evaluated in 10 conscious dogs with well developed collateral vessels. Collateral growth was promoted by brief, repeated, reversible coronary occlusions. After partial regression in collateral function a small dose of glyceryl trinitrate (5 micrograms.kg-1) was injected intravenously 1 min before coronary occlusion. After pretreatment with glyceryl trinitrate the collateral blood flow velocity (mean[SD]) increased from 3.0(0.9) to 4.4(1.4) cm.s-1 (p less than 0.05). After 2 min of occlusion the percentage systolic subendocardial segment shortening in the collateral dependent zone increased from 7.8(6.1) to 12.6(6.7)% (p less than 0.05). The blood flow debt repayment after release of the occlusion decreased from 122(41) to 68(34%) (p less than 0.05). Thus in conscious dogs with regressed newly developed collaterals a major component of the beneficial effects of glyceryl trinitrate on collateral circulation is dilatation of collateral vessels, as evidenced by a pronounced increase in collateral blood flow and myocardial function during a transient period of coronary occlusion.